FDA clears Sanofi's Nasacort for OTC use

Sanofi announced Friday that the FDA has granted its allergy spray Nasacort approval to be sold over the counter in drugstores. The medication, which was approved to treat adults and children 2 and older with allergies, was the first steroid nasal spray to attain clearance for OTC use.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA